1066270

Stephen K. Tyring, MD, PhD — FEI 3011360956

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 20, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
752021 CFR 312.64(b)Safety reports
756021 CFR 312.60FD-1572, protocol compliance